Sui Chung, of Americans for Immigrant Justice, talks about immigration enforcement in Florida
Jim talks to Sui Chung, the executive director of Americans for Immigrant Justice. The two discuss immigration enforcement here, specifically what is happening inside local detention centers like Krome. She has been documenting the conditions, and shares how they have deteriorated when it comes to overcrowding, as well as access to counsel, and medical care
Guest: Sui Chung/Exec. Dir., Americans for Immigrant Justice
About the issue
The Krome Detention Center may soon house more immigrants under tent structures as overcrowding concerns grow, according to U.S. Rep. Frederica Wilson.
Family member describes overcrowding conditions
Jessica Rodriguez said her husband, Josue Aguilar, 27, was transferred to Krome two weeks ago after being detained at a U.S. immigration services office.
Aguilar told her the facility was overcrowded and detainees were lying on the floor. "He would tell me 20 people would be taken out and 50 would come in," she said.
Rodriguez reached out to Rep. Wilson, a Democrat representing South Florida, who requested a tour of the immigration facility. Wilson also reviewed social media video reportedly taken by a detainee describing a lack of cleanliness.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report?
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering CVS Health (CVS), which belongs to the Zacks Medical Services industry. When looking at the last two reports, this drugstore chain and pharmacy benefits manager has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 32.64%, on average, in the last two quarters. For the last reported quarter, CVS Health came out with earnings of $2.25 per share versus the Zacks Consensus Estimate of $1.71 per share, representing a surprise of 31.58%. For the previous quarter, the company was expected to post earnings of $0.89 per share and it actually produced earnings of $1.19 per share, delivering a surprise of 33.71%. Thanks in part to this history, there has been a favorable change in earnings estimates for CVS Health lately. In fact, the Zacks Earnings ESP (Expected Surprise Prediction) for the stock is positive, which is a great indicator of an earnings beat, particularly when combined with its solid Zacks Rank. Our research shows that stocks with the combination of a positive Earnings ESP and a Zacks Rank #3 (Hold) or better produce a positive surprise nearly 70% of the time. In other words, if you have 10 stocks with this combination, the number of stocks that beat the consensus estimate could be as high as seven. The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a version of the Zacks Consensus whose definition is related to change. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier. CVS Health has an Earnings ESP of +6.35% at the moment, suggesting that analysts have grown bullish on its near-term earnings potential. When you combine this positive Earnings ESP with the stock's Zacks Rank #2 (Buy), it shows that another beat is possibly around the corner. The company's next earnings report is expected to be released on July 31, 2025. With the Earnings ESP metric, it's important to note that a negative value reduces its predictive power; however, a negative Earnings ESP does not indicate an earnings miss. Many companies end up beating the consensus EPS estimate, but that may not be the sole basis for their stocks moving higher. On the other hand, some stocks may hold their ground even if they end up missing the consensus estimate. Because of this, it's really important to check a company's Earnings ESP ahead of its quarterly release to increase the odds of success. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report CVS Health Corporation (CVS) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
27 minutes ago
- Yahoo
Obvious Losers, Unexpected Winners As Tax Bill Passes Senate
Clean energy stocks delivered mixed performances on Wednesday as investors continued digesting the Senate's surprise revisions to President Trump's 'big, beautiful bill.' Utility-scale solar firms remained under pressure, while residential solar, hydrogen, and U.S.-based battery storage companies extended gains amid signs the legislation favors domestic supply chains and penalizes projects linked to China. NextEra Energy (NYSE:NEE) slipped another 1.2% on Wednesday, compounding earlier losses, while AES Corp. (NYSE:AES) closed flat after a two-day decline of more than 6%. Shoals Technologies (NASDAQ:SHLS), already down over 14% on Monday, dropped another 3.6% Wednesday. Nextracker (NASDAQ:NXT) slid 2.4%, and Enphase Energy (NASDAQ:ENPH) shed another 4.2%, extending its weekly decline past 15%. Array Technologies (NASDAQ:ARRY) was down 1.8% Wednesday, failing to recover from Monday's -10.1% plunge, as investors reassessed the near-term pipeline risk from the new operational deadline for tax credit eligibility. But There Are Winners, Too … Sunrun (NASDAQ:RUN) added 2.7% Wednesday, bringing its weekly gain to nearly 17% as markets priced in a more favorable outlook for distributed solar. First Solar (NASDAQ:FSLR) advanced another 1.5% on the day following two strong sessions. Analysts at Jefferies upgraded the stock, calling it a key winner from U.S. content incentives and tariffs on Chinese materials. Fluence Energy (NASDAQ:FLNC) and Eos Energy Enterprises (NASDAQ:EOSE), both operating battery storage projects in the U.S., gained 3.1% and 2.5% respectively. As noted here, traders continue rotating into companies best positioned to meet the new sourcing and operations deadlines. And Hydrogen is getting a boost, as well. Hydrogen stocks surged for a third straight session after the Senate unexpectedly extended the 45V clean hydrogen production tax credit to 2027. Plug Power (NASDAQ:PLUG) soared another 8.2% Wednesday, bringing its three-day gain to more than 40%. Bloom Energy (NYSE:BE) added 3.4%, and Ballard Power Systems (NASDAQ:BLDP) rose 2.2%, supported by increasing optimism that delayed U.S. hydrogen projects will now move forward under more favorable terms. Coal, nuclear, and legacy energy stocks have also caught the tailwinds. Steelmaking coal producers continued to gain on Wednesday after the bill granted critical minerals tax credit eligibility to metallurgical coal. Alpha Metallurgical Resources (NYSE:AMR) rose 1.9%, Warrior Met Coal (NYSE:HCC) added 2.4%, and Peabody Energy (NYSE:BTU) was up 1.5%. Meanwhile, uranium and nuclear-linked equities also saw light buying as the bill preserved tax credits for non-carbon baseload power including nuclear, hydro, and geothermal. Cameco (NYSE:CCJ) and Constellation Energy (NASDAQ:CEG) rose modestly, up 0.7% and 1.1% respectively. Policy In the Volatility Driver's Seat The Senate bill tightens tax credit qualification rules by requiring renewable projects to be operational by 2027, rather than just under construction. It also levies new taxes on projects that use Chinese-sourced materials and allows some carveouts for clean hydrogen and domestic manufacturers. According to Rhodium Group estimates, the combination of tax loss and China-linked penalties could raise project costs by up to 20%, with developers likely to pass that through in electricity prices. The American Clean Power Association warned of an 8–10% rise in consumer electricity bills if the proposal is enacted. With the bill headed back to the House for reconciliation, market participants are bracing for additional volatility. Fiscal conservatives are expected to contest the Senate version's deficit impact—estimated to add roughly $1 trillion more than the House-passed bill from May. For now, traders are positioning around likely winners with U.S.-centric supply chains, while pricing in risk for utility-scale developers with international exposure. By Alex Kimani for More Top Reads From this article on
Yahoo
27 minutes ago
- Yahoo
UnitedHealth Group (UNH) Stock Sinks As Market Gains: What You Should Know
UnitedHealth Group (UNH) closed the most recent trading day at $307.56, moving -5.7% from the previous trading session. The stock fell short of the S&P 500, which registered a gain of 0.48% for the day. Elsewhere, the Dow lost 0.02%, while the tech-heavy Nasdaq added 0.94%. Shares of the largest U.S. health insurer witnessed a gain of 8.27% over the previous month, beating the performance of the Medical sector with its gain of 2.8%, and the S&P 500's gain of 5.13%. The investment community will be closely monitoring the performance of UnitedHealth Group in its forthcoming earnings report. The company is scheduled to release its earnings on July 29, 2025. The company's earnings per share (EPS) are projected to be $5.08, reflecting a 25.29% decrease from the same quarter last year. Alongside, our most recent consensus estimate is anticipating revenue of $111.85 billion, indicating a 13.14% upward movement from the same quarter last year. For the annual period, the Zacks Consensus Estimates anticipate earnings of $22.07 per share and a revenue of $449.46 billion, signifying shifts of -20.21% and +12.29%, respectively, from the last year. Investors should also pay attention to any latest changes in analyst estimates for UnitedHealth Group. These recent revisions tend to reflect the evolving nature of short-term business trends. As such, positive estimate revisions reflect analyst optimism about the business and profitability. Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system. The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 3.54% lower. As of now, UnitedHealth Group holds a Zacks Rank of #4 (Sell). From a valuation perspective, UnitedHealth Group is currently exchanging hands at a Forward P/E ratio of 14.78. This indicates a premium in contrast to its industry's Forward P/E of 13.39. One should further note that UNH currently holds a PEG ratio of 1.55. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The Medical - HMOs industry had an average PEG ratio of 1.01 as trading concluded yesterday. The Medical - HMOs industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 34, finds itself in the top 14% echelons of all 250+ industries. The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Remember to apply to follow these and more stock-moving metrics during the upcoming trading sessions. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report UnitedHealth Group Incorporated (UNH) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
